Can Live Vaccines Be Given Immediately After Cosentyx?
The use of live vaccines after Cosentyx (secukinumab) treatment is a topic of concern due to the potential interference with the immune system. Cosentyx is a monoclonal antibody that targets interleukin-17A (IL-17A) and is used to treat various autoimmune diseases, including psoriasis, psoriatic arthritis, and ankylosing spondylitis [1].
Interactions with Live Vaccines
When taking live vaccines, it is essential to ensure that the immune system is functioning properly. Live vaccines contain weakened or attenuated forms of the pathogen, and a healthy immune system can help prevent the replication of the virus in the body.
However, the use of Cosentyx may lead to a weakened immune system, as it can suppress the body's response to certain pathogens. Therefore, experts advise caution when administering live vaccines concurrently with Cosentyx or during the treatment period.
Guidelines and Recommendations
According to the Cosentyx prescribing information, live vaccines should not be given concurrently with secukinumab. Live vaccines should also be avoided for at least 4 weeks after stopping secukinumab [2].
In contrast, inactivated vaccines can be administered concurrently with Cosentyx. Inactivated vaccines contain killed or inactivated pathogens, which cannot replicate in the body and do not require a functioning immune system to work.
When Can Live Vaccines Be Given?
If a patient requires a live vaccine, it is best to delay its administration until they have completed their Cosentyx treatment. The exact timing will depend on the individual's treatment duration and medical history.
Patients should consult with their healthcare provider before receiving any vaccinations, as they can assess the risk-benefit ratio for each vaccine and provide personalized guidance.
Patent Expiration and Alternatives
Cosentyx's patent expiration date varies by country and may have implications for the availability of competing products [3]. In the US, the patent is expected to expire in 2026, potentially leading to the introduction of biosimilar versions.
Contraindications and Side Effects
While the use of live vaccines with Cosentyx may be contraindicated, it is essential to discuss any concerns with your healthcare provider, as the benefits of vaccination may outweigh the potential risks in certain situations.
In conclusion, due to the potential interference with the immune system, live vaccines should not be given immediately after Cosentyx treatment. Consult with your healthcare provider to determine the best course of action.
Sources
[1] Cosentyx prescribing information. (2022). Retrieved from https://www.cosentyx.com/prescribing-information
[2] Cosentyx prescribing information. (2022). Retrieved from https://www.cosentyx.com/prescribing-information
[3] DrugPatentWatch.com. (2022). Retrieved from https://www.drugpatentwatch.com/cosentyx